ÖZDARENDELİ, A. Et Al. 2023. Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials. Vaccine , vol.41, no.2 , 380-390.

ÖZDARENDELİ, A., SEZER, Z., PAVEL, S. T. I., İNAL, A., YETİŞKİN, H., KAPLAN, B., ... UYGUT, M. A.(2023). Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials. Vaccine , vol.41, no.2, 380-390.

ÖZDARENDELİ, AYKUT Et Al. "Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials," Vaccine , vol.41, no.2, 380-390, 2023

ÖZDARENDELİ, AYKUT Et Al. "Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials." Vaccine , vol.41, no.2, pp.380-390, 2023

ÖZDARENDELİ, A. Et Al. (2023) . "Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials." Vaccine , vol.41, no.2, pp.380-390.

@article{article, author={AYKUT ÖZDARENDELİ Et Al. }, title={Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials}, journal={Vaccine}, year=2023, pages={380-390} }